Sprint Bioscience AB
F:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sprint Bioscience AB
F:5JA1
|
SE |
|
ACS Actividades de Construccion y Servicios SA
MAD:ACS
|
ES |
|
3
|
3D Systems Corp
F:SYV
|
US |
|
Unipol Gruppo SpA
MIL:UNI
|
IT |
|
S
|
Starbucks Corp
XHAM:SRB
|
US |
Wall St Price Targets
5JA1 Price Targets Summary
Sprint Bioscience AB
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.05 EUR with a low forecast of 0.05 EUR and a high forecast of 0.052 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5JA1's stock price target?
Price Target
0.05
EUR
According to Wall Street analysts, the average 1-year price target for 5JA1 is 0.05 EUR with a low forecast of 0.05 EUR and a high forecast of 0.052 EUR.
What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%
Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.
What is the Gross Profit forecast for Sprint Bioscience AB?
Projected CAGR
-24%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 2 years is -24%.
What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%
The compound annual growth rate for Operating Income over the next 3 years is -73%.
What is the Pre-Tax Income forecast for Sprint Bioscience AB?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 2 years is -20%.
What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-15%
The compound annual growth rate for Net Income over the next 2 years is -15%.
